Uni-Bio Science Group (HKG:0690) received marketing approval for its Diquafosol Sodium eye drops from China's National Medical Products Administration, a Wednesday Hong Kong bourse filing said.
The eye drops are suitable for patients diagnosed with dry eye accompanied by abnormal tear-associated corneal epithelial defects.